Twinbeech Capital LP Revolution Medicines, Inc. Transaction History

Twinbeech Capital LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$30.14 - $40.68 $6.64 Million - $8.96 Million	220,289 New	220,289 $8.55 Million
Q4 2023 Feb 14, 2024	SELL	$18.35 - $34.12 $3.28 Million - $6.1 Million	-178,659 Reduced 95.98%	7,486 $214,000
Q3 2023 Nov 14, 2023	BUY	$25.17 - $35.05 $4.69 Million - $6.52 Million	186,145 New	186,145 $5.15 Million
Q1 2023 May 15, 2023	BUY	$20.76 - $30.09 $3.37 Million - $4.88 Million	162,148 New	162,148 $3.51 Million
Q3 2021 Nov 15, 2021	SELL	$23.95 - $33.41 $495,788 - $691,620	-20,701 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$29.0 - $47.44 $600,329 - $982,055	20,701 New	20,701 $657,000

266

161M

260K

620K

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.8B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.